Effects of an In-Home Treatment Program for First Responders With Substance Use Disorder: A Retrospective Analysis
Retrospective analysis to evaluate impact of an in-home addiction treatment program on first responders with substance use disorder.
NCT03907709 — Substance Use Disorders
Status: Suspended
http://inclinicaltrials.com/substance-use-disorders/NCT03907709/
Addiction Recovery in a Rural Minnesota Community: Piloting "Positive Peer Journaling" Part II
The main objective of this study is development of the Positive Peer Journaling (PPJ) intervention and the feasibility, acceptability, and logistics of treatment delivery. A second objective is to observe whether PPJ is associated with improvement in hypothesized outcomes. The primary outcomes the investigators will examine are enhanced treatment retention and reduced recurrence of substance use. The investigators will also explore the association between the intervention and a set of hypothesized mediators of the effect of the intervention on outcomes, e.g., improvement in mood and satisfaction with recovery.
NCT03903159 — Addiction
Status: Completed
http://inclinicaltrials.com/addiction/NCT03903159/
Outcomes Related to Use of Soberlink Within In-Home Addiction Treatment Program for Individuals With Alcohol Use Disorder
The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.
NCT03902171 — Alcohol Use Disorder
Status: Enrolling by invitation
http://inclinicaltrials.com/alcohol-use-disorder/NCT03902171/
Optimizing HIV Care for Patients With Substance Use Disorders Using Predictive Analytics in a Mobile Health Application
It is now well-accepted that lowering community-level viral load through expansion of antiretroviral therapy (ART) can reduce HIV transmission among people who use drugs. However, achieving durable viral suppression among patients with substance use disorders is a major challenge for providers and health systems. This study aims to adapt and implement an existing mobile health (mHealth) system, A-CHESS (Addiction Comprehensive Health Enhancement Support System) to improve care for HIV patients with substance use disorders.
NCT03873129 — HIV/AIDS
Status: Completed
http://inclinicaltrials.com/hiv-aids/NCT03873129/
Transcranial Direct Current Stimulation (tDCS) to Reduce Craving in Cocaine Addiction
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In the present study, tDCS will be administered with the goal of assessing the tolerability and feasibility of this approach to 1) reduce an individual's level of drug craving and 2) provide evidence to support the use of this device by the patient for future unsupervised stimulation in a non-clinical setting. Research Questions: - Can tDCS be used successfully to train cocaine addicted individuals for self-administration purposes? - Can active tDCS be used to decrease drug craving in individuals with cocaine use disorders? - Does active tDCS outperform sham tDCS in reducing drug craving?
NCT03833583 — Cocaine Dependence
Status: Recruiting
http://inclinicaltrials.com/cocaine-dependence/NCT03833583/
Nanoencapsulated Cannabidiol Time Released Capsules Targeted to Reduce Cravings in the Treatment of Opioid Addiction
The purpose of this study is determine the safety, efficacy and tolerability of a novel drug APH-1501 as a pharmacotherapy for Opioid Dependence. The investigators will evaluate the safety of escalating doses APH-1501.
NCT03813095 — Opioid Dependence
Status: Not yet recruiting
http://inclinicaltrials.com/opioid-dependence/NCT03813095/
Stress-related Predictor Profiles for Craving and Relapse in Human Addiction
Long-term aim is the definition of a setup of mobile sensors and their integration in a mobile infrastructure that allows the prediction of stress related alcohol intake in an ambulatory setting. Here, we aim to identify stress- and alcohol cue-related physiological markers in a lab experiment to assess interactions between acute psychological vs. physical stress exposure and alcohol cue-exposure regarding their effects on measures relevant for the development and maintenance of Alcohol Use Disorder (AUD). Further, we aim to identify neural correlates in brain circuits of motivational, cognitive, and affective processing. In addition to applying established stress-related markers, we will integrate innovative sensor-based measures.
NCT03810924 — Alcohol Use Disorder
Status: Completed
http://inclinicaltrials.com/alcohol-use-disorder/NCT03810924/
Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction, In Adults Undergoing Opioid Addiction Treatment
This study demonstrates the feasibility, acceptability of SKY program as an adjuvant therapy for American population suffering with OUD through a pilot program in Columbus, Ohio. The aim of this study is to evaluate the SKY program as an adjuvant therapy to treat opioid addiction.
NCT03791645 — Opioid Use
Status: Completed
http://inclinicaltrials.com/opioid-use/NCT03791645/
Investigation of the Relationship of Smart Phone Use Addiction With Musculoskeletal System Problems and Cognitive Flexibility
Smartphones have become a part of everyday life, but with some problems. Researches have pointed out that smartphone addiction can cause both physical and mental problems.
NCT03772782 — Smartphone
Status: Completed
http://inclinicaltrials.com/smartphone/NCT03772782/
Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial
The purpose of this study is to compare the efficacy and cost-effectiveness of a Computer-based Training for Cognitive Behavioural Therapy (CBT4CBT) to treatment as usual in outpatients seeking treatment for substance use disorder.
NCT03767907 — Substance Dependence
Status: Completed
http://inclinicaltrials.com/substance-dependence/NCT03767907/